Immupharma PLC Grant of Options (8456K)
July 12 2017 - 6:00AM
UK Regulatory
TIDMIMM
RNS Number : 8456K
Immupharma PLC
12 July 2017
12 July 2017
Grant of Options
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, announces the
approval of the grant of options over 1,400,000 ordinary shares of
10p each ("Ordinary Shares") to certain of its non-executive
Directors representing 1.06% of ImmuPharma's Ordinary Shares and
total voting rights on a fully diluted basis. The exercise price
for these options is 56.75p pence being the closing middle market
share price on 11 July 2017. The options will vest after three
years and are exercisable between three and ten years from the date
of grant.
The amount of options granted to non-executive Directors are
summarised in the following table:
Director Ordinary Shares
under Option
----------------- ----------------
Tim McCarthy 1,000,000
----------------- ----------------
Franco di Muzio 200,000
----------------- ----------------
Stephane Mery 200,000
----------------- ----------------
Following this grant of all options on the above date, the total
number of share options outstanding will be 8,233,850 representing
6.2% of ImmuPharma's Ordinary Shares and total voting rights on a
fully diluted basis.
Messrs McCarthy, di Muzio and Mery currently have the following
interests in issued Ordinary Shares:
Director Number of % of issued share
Ordinary Shares capital
at 11 July 2017
----------------- ----------------- -----------------
Tim McCarthy 38,462 0.03%
----------------- ----------------- -----------------
Franco di Muzio 99,412 0.08%
----------------- ----------------- -----------------
Stephane Mery 21,490 0.02%
----------------- ----------------- -----------------
Following the grant of the options referred to above, Messrs
McCarthy, di Muzio and Mery will have the following interests in
options over the Company's Ordinary Shares:
Director Number of Exercise Price Expiry Date
Ordinary
Shares under
option
-------------- -------------- -------------- -----------
Tim McCarthy 500,000 43.88p 02.06.2026
1,000,000 56.75p 12.07.2027
-------------- -------------- -------------- -----------
Franco di 100,000 76.80p 31.07.2017
Muzio
100,000 86.50p 04.02.2019
100,000 43.88p 02.06.2026
200,000 56.75p 12.07.2027
-------------- -------------- -------------- -----------
Stephane Mery 100,000 43.88p 02.06.2026
200,000 56.75p 12.07.2027
-------------- -------------- -------------- -----------
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
Ends
For further information please contact:
+ 44 (0) 20
ImmuPharma plc (www.immupharma.org) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor
Relations + 44 (0) 7721
Twitter: @immupharma 413496
Northland Capital Partners Limited
(NOMAD & Broker)
Patrick Claridge, David Hignell,
Jamie Spotswood, Corporate Finance +44 (0)20 3861
Rob Rees, Corporate Broking 6625
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHRTMLTMBABMMR
(END) Dow Jones Newswires
July 12, 2017 06:00 ET (10:00 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2023 to Apr 2024